高级检索
当前位置: 首页 > 详情页

Association between P16 promoter methylation and thyroid cancer risk: A meta-analysis(Open Access)

文献详情

资源类型:
WOS体系:
Pubmed体系:
机构: [a]Laboratory of Molecular Genetics of Aging and Tumor, Faculty of Medicing, Kunming University of Science and Technology, Kunming, Yunnan, China [b]Department of Pharmacy, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China
出处:
ISSN:

关键词: Meta-analysis P16 promoter methylation Thyroid cancer

摘要:
Background: The aim of the meta-analysis was to derive a more precise assessment of the association between p16 promoter methylation and thyroid cancer risk. Materials and Methods: The PubMed, Web of Science databases and Chinese CNKI were searched for relevant articles. Ultimately, seventeen case-control studies were included with a total of 804 thyroid cancer cases and 487 controls analysis by R Software (R version 3.1.2) including meta. Crude odds ratios with 95% confidence intervals were calculated using the random-effects model which were used to assess the strength of relationship between p16 methylation and lung carcinogenesis. Funnel plots were carried out to evaluate publication bias. Results: The meta-analysis results showed that the frequency of p16 promoter methylation in cancer tissue/blood was significantly higher than that normal tissue/blood (OR=5.46, 95%CI 3.12-9.55, P<0.0001) by random effects model with small heterogeneity. Conclusions: Thus, p16 promoter methylation may be associated with thyroid cancer risk.

基金:
语种:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2023]版:
第一作者:
第一作者机构: [a]Laboratory of Molecular Genetics of Aging and Tumor, Faculty of Medicing, Kunming University of Science and Technology, Kunming, Yunnan, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82478 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号